The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 27, 2021

Filed:

Jan. 30, 2020
Applicant:

Contrafect Corporation, Yonkers, NY (US);

Inventor:

Raymond Schuch, Mountain Lakes, NJ (US);

Assignee:

CONTRAFECT CORPORATION, Yonkers, NY (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61P 31/04 (2006.01); C07K 14/47 (2006.01); C12N 15/64 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 9/107 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/4723 (2013.01); A61P 31/04 (2018.01); C12N 15/64 (2013.01); A61K 9/0073 (2013.01); A61K 9/107 (2013.01); A61K 38/00 (2013.01); A61K 45/06 (2013.01);
Abstract

The present disclosure is directed to a lysin-AMP polypeptide construct comprising: (a) a first component comprising the polypeptide sequence of: (i) SEQ ID NO: 118 (GN202); or (ii) a polypeptide having lysin activity and having at least 80% sequence identity with the polypeptide sequence of SEQ ID NO: 118 (GN202); or (iii) an active fragment of SEQ ID NO: 118 (GN202); and (b) a second component comprising the polypeptide sequence of at least one antimicrobial peptide (AMP), wherein the at least one AMP comprises SEQ ID NO: 114 (FIRL). Exemplary lysin-AMP polypeptides, such as GN370 (SEQ ID NO: 44) as well as methods of treating bacterial infections using the present lysin-AMP polypeptide constructs are also disclosed.


Find Patent Forward Citations

Loading…